Rafael Holdings, Inc. is 10% Owner at Cyclo Therapeutics, Inc. (CYTH). They have made 1 open-market trade across 1 company since 2023, most recently 2024-12-23.
CIK 0001713863
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYTH | 12,998,194 | $9.4M |
Shares reported on the most recent Form 4, priced at the 2025-01-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYTH | BUY | 2023-08-01 | 2023-08-02 | $1.25 | $5.0M | -8.8% | +1.9% | -39.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.